$SHC
Sotera Health Co Stock $shc

$shc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000182247923000033 Filed on May 03, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$255.3M	$220.6M	$236.8M
YoY Change	-4.26%	-6.83%	11.6%
Cost Of Revenue	$115.7M	$109.1M	$107.9M
YoY Change	-0.47%	1.12%	11.47%
Gross Profit	$139.6M	$111.5M	$128.9M
YoY Change	-7.19%	-13.48%	11.7%
Gross Profit Margin	54.68%	50.55%	54.43%
Selling, General & Admin	$60.29M	$61.91M	$59.54M
YoY Change	-4.51%	3.98%	13.49%
% of Gross Profit	43.19%	55.52%	46.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$39.49M	$18.93M	$15.87M
YoY Change	6.9%	19.31%	3.17%
% of Gross Profit	28.29%	16.98%	12.31%
Operating Expenses	$76.38M	$78.14M	$75.38M
YoY Change	-3.19%	3.65%	9.24%
Operating Profit	$63.20M	$33.37M	$53.49M
YoY Change	-11.6%	-37.62%	15.37%
Interest Expense	-$30.73M	-$28.87M	-$10.40M
YoY Change	118.8%	177.49%	-51.11%
% of Operating Profit	-48.62%	-86.53%	-19.45%
Other Income/Expense, Net	$2.474M	$1.253M	$2.967M
YoY Change	-610.1%	-57.77%	-23.73%
Pretax Income	$34.49M	$5.402M	$45.27M
YoY Change	-28.32%	-88.07%	221.45%
Income Tax	$10.97M	$2.560M	$14.63M
% Of Pretax Income	31.82%	47.39%	32.31%
Net Earnings	$23.51M	$2.842M	$30.64M
YoY Change	-22.7%	-90.72%	182.61%
Net Earnings / Revenue	9.21%	1.29%	12.94%
Basic Earnings Per Share	$0.08	$0.01	$0.11
Diluted Earnings Per Share	$0.08	$0.01	$0.11
COMMON SHARES
Basic Shares Outstanding	282.5M shares	282.4M shares	279.8M shares
Diluted Shares Outstanding	283.1M shares	283.0M shares	279.9M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$262.7M	$647.9M	$121.4M
YoY Change	88.23%	433.55%	12.44%
Cash & Equivalents	$262.7M	$647.9M	$121.4M
Short-Term Investments
Other Short-Term Assets	$14.63M	$11.87M	$16.36M
YoY Change	26.39%	-27.41%	39.06%
Inventory	$42.10M	$46.74M	$45.70M
Prepaid Expenses
Receivables	$117.3M	$109.2M	$114.8M
Other Receivables	$31.48M	$26.14M	$11.00M
Total Short-Term Assets	$546.7M	$923.8M	$371.6M
YoY Change	37.13%	148.63%	13.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$884.3M	$841.1M	$669.2M
YoY Change	26.41%	25.7%	9.41%
Goodwill	$1.110B	$1.103B	$1.126B
YoY Change	-0.49%	-1.99%	1.73%
Intangibles	$456.1M	$471.9M	$582.1M
YoY Change	-16.01%	-18.94%	-11.34%
Long-Term Investments			$9.550M
YoY Change			3.5%
Other Assets	$34.08M	$32.91M	$27.49M
YoY Change	-11.03%	19.72%	196.17%
Total Long-Term Assets	$2.528B	$2.490B	$2.464B
YoY Change	3.57%	1.06%	0.64%
TOTAL ASSETS
Total Short-Term Assets	$546.7M	$923.8M	$371.6M
Total Long-Term Assets	$2.528B	$2.490B	$2.464B
Total Assets	$3.075B	$3.414B	$2.836B
YoY Change	8.28%	20.4%	2.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$55.58M	$61.94M	$55.22M
YoY Change	-14.85%	12.17%	-3.42%
Accrued Expenses	$103.5M	$496.8M	$60.46M
YoY Change	96.46%	721.7%	7.25%
Deferred Revenue	$13.80M	$15.20M	$12.90M
YoY Change	100.0%	17.83%	115.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.225M	$4.031M	$1.342M
YoY Change	223.53%	200.37%	22.0%
Total Short-Term Liabilities	$200.3M	$600.1M	$143.9M
YoY Change	41.06%	317.2%	4.23%
LONG-TERM LIABILITIES
Long-Term Debt	$2.222B	$2.222B	$1.745B
YoY Change	23.26%	27.39%	-5.06%
Other Long-Term Liabilities	$12.63M	$15.05M	$16.19M
YoY Change	-19.42%	-7.02%	-13.87%
Total Long-Term Liabilities	$2.235B	$2.237B	$1.761B
YoY Change	14162.27%	27.07%	-5.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$200.3M	$600.1M	$143.9M
Total Long-Term Liabilities	$2.235B	$2.237B	$1.761B
Total Liabilities	$2.657B	$3.053B	$2.194B
YoY Change	20.55%	39.18%	-5.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$679.5M	-$703.0M	-$441.6M
YoY Change	65.24%	59.19%	-23.64%
Common Stock	$2.860M	$2.860M	$2.860M
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$29.42M	$33.54M
YoY Change		-12.27%	-1.36%
Treasury Stock Shares		3.520M shares	3.107M shares
Shareholders Equity	$418.4M	$361.1M	$642.1M
YoY Change
Total Liabilities & Shareholders Equity	$3.075B	$3.414B	$2.836B
YoY Change	8.28%	20.4%	2.12%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$23.51M	$2.842M	$30.64M
YoY Change	-22.7%	-90.72%	182.61%
Depreciation, Depletion And Amortization	$39.49M	$18.93M	$15.87M
YoY Change	6.9%	19.31%	3.17%
Cash From Operating Activities	-$336.6M	$33.87M	$49.97M
YoY Change	-677.42%	-32.21%	-11.03%
INVESTING ACTIVITIES
Capital Expenditures	$53.13M	$45.00M	$35.55M
YoY Change	-247.2%	26.6%	69.74%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$0.00	-$32.00K	$63.00K
YoY Change	-100.0%	-150.79%	-100.25%
Cash From Investing Activities	-$53.13M	-$44.97M	-$35.48M
YoY Change	48.8%	26.73%	-23.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$200.0M	$0.00
YoY Change
Cash From Financing Activities	-710.0K	$273.9M	-$449.0K
YoY Change	11.99%	-61105.79%	-88.13%
NET CHANGE
Cash From Operating Activities	-336.6M	$33.87M	$49.97M
Cash From Investing Activities	-53.13M	-$44.97M	-$35.48M
Cash From Financing Activities	-710.0K	$273.9M	-$449.0K
Net Change In Cash	-390.4M	$263.9M	$14.52M
YoY Change	-1879.0%	1717.15%	161.09%
FREE CASH FLOW
Cash From Operating Activities	-$336.6M	$33.87M	$49.97M
Capital Expenditures	$53.13M	$45.00M	$35.55M
Free Cash Flow	-$389.7M	-$11.13M	$14.42M
YoY Change	-512.89%	-177.17%	-59.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001822479
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39729
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SOTERA HEALTH COMPANY
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3531161
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	9100 South Hills Blvd
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Broadview Heights
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44147
CY2023Q1	dei	City Area Code CityAreaCode	440
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	262-1410
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	SHC
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	282516526	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	647948000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	395214000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	12232000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1080000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2587000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1871000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	109163000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	118482000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	46736000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	37145000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87303000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	80995000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	20417000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	12094000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	923799000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	645010000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	816164000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	774527000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	24941000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26481000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4165000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4101000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	36915000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	35570000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	32909000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	38983000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	471860000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	491265000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1103420000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1101768000	usd
CY2023Q1	us-gaap	Assets Assets	3414173000	usd
CY2022Q4	us-gaap	Assets Assets	3117705000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	61939000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	74139000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	496791000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	490130000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15161000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12140000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	4031000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	197119000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8588000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1722000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6942000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7554000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	2108000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	2896000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4589000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5867000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	600149000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	791567000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2222333000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1747115000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	61735000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	56955000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20561000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21577000	usd
CY2023Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	43350000	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	42586000	usd
CY2023Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	18785000	usd
CY2022Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	18902000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	7858000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	7910000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15051000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12831000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	63226000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	68024000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3053048000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2767467000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	286037000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	286037000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2860000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2860000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	120000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	120000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	3520000	shares
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	3616000	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	29420000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	29775000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1195357000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1189622000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-702974000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-705816000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-104698000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-106653000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	361125000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	350238000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3414173000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3117705000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	220590000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	236754000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	109087000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	107879000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	111503000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	128875000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	61910000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	59542000	usd
CY2023Q1	shc	Amortization Of Intangible Assets Nonproduction AmortizationOfIntangibleAssetsNonproduction	16227000	usd
CY2022Q1	shc	Amortization Of Intangible Assets Nonproduction AmortizationOfIntangibleAssetsNonproduction	15841000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	78137000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	75383000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	33366000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	53492000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-28870000	usd
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-10404000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-347000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-788000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1253000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2967000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5402000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45267000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2560000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14626000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2842000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	30641000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	17000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	92000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	51000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	274000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-3396000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	2109000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-9251000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	6179000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	11257000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	14975000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	4797000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	51521000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	280691000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	279829000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	282977000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	279908000	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2842000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	30641000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	18931000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	15867000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20607000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20182000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1770000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5633000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7288000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4538000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	572000	usd
CY2022Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	520000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-802000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2430000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-227000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	7364000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1910000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1414000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1328000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1989000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10223000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6387000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9512000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9323000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	6318000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	8934000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9610000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12742000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8826000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2479000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-9551000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-5222000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-372000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-81000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-104000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	341000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	33871000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	49967000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45000000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35546000	usd
CY2023Q1	shc	Payments To Acquire Businesses Net Of Cash Acquired Adjustments PaymentsToAcquireBusinessesNetOfCashAcquiredAdjustments	0	usd
CY2022Q1	shc	Payments To Acquire Businesses Net Of Cash Acquired Adjustments PaymentsToAcquireBusinessesNetOfCashAcquiredAdjustments	-63000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-32000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-44968000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35483000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	500000000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	200000000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	24457000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	31000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1627000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-418000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	273916000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-449000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1067000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	487000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	263886000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14522000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	396294000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106924000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	660180000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121446000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	35456000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	15809000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	14014000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13505000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13061000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9508000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	586096000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4513000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	274000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	14975000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	6179000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	30641000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	642130000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	350238000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6090000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	51000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	11257000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-9251000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2842000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	361125000	usd
CY2023Q1	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Sotera Health Company (also referred to herein as the “Company,” “we,” “our,” “us” or “its”), is a global provider of mission-critical sterilization and lab testing and advisory services to the medical device and pharmaceutical industries with operations primarily in the Americas, Europe and Asia. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate and report in three segments, Sterigenics, Nordion and Nelson Labs. We describe our reportable segments in Note 17, “Segment Information”. All significant intercompany balances and transactions have been eliminated in consolidation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we acquired a 60% equity ownership interest in a joint venture to construct an E-beam facility in Alberta, Canada in connection with our acquisition of Iotron Industries Canada, Inc. (“Iotron”). Our equity ownership interest in the joint venture was determined to be an investment in a variable interest entity (“VIE”). The investment was not consolidated as the Company concluded that it was not the primary beneficiary of the VIE. The Company accounted for the joint venture using the equity method. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, we identified certain events and circumstances that indicated a decline in value of our investment in this joint venture that was other-than-temporary. Consequently, in the second quarter of 2022, we wrote down the investment in the joint venture to its fair value of $0, resulting in an impairment charge of approximately $9.6 million. In February 2023, we entered into a Share Purchase Agreement to transfer our equity ownership interest to the joint venture partner, thereby terminating our equity ownership interest.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – In preparing our consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”), we make estimates and assumptions that affect the amounts reported and the accompanying notes. We regularly evaluate the estimates and assumptions used and revise them as new information becomes available. Actual results may vary from those estimates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">– The accompanying consolidated financial statements include the assets, liabilities, operating results, and cash flows of the Company and its wholly owned subsidiaries. These financial statements are prepared in accordance with U.S. GAAP for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. These unaudited interim financial statements should be read in conjunction with the Company's annual consolidated financial statements and accompanying notes on Form 10-K for the year ended December 31, 2022.</span></div>
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates – In preparing our consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”), we make estimates and assumptions that affect the amounts reported and the accompanying notes. We regularly evaluate the estimates and assumptions used and revise them as new information becomes available. Actual results may vary from those estimates.
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	220590000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	236754000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	18700000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	19800000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15200000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12100000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	37145000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	46736000	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	39616000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	36402000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1554000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	584000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5682000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	276000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	46852000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	37262000	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	116000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	117000	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	26426000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	26598000	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	8184000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	9964000	usd
CY2023Q1	us-gaap	Prepaid Rent PrepaidRent	1072000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	998000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	18736000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	19777000	usd
CY2023Q1	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	3529000	usd
CY2022Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	3724000	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	396000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	660000	usd
CY2023Q1	shc	Prepaid Maintenance Contracts Current PrepaidMaintenanceContractsCurrent	517000	usd
CY2022Q4	shc	Prepaid Maintenance Contracts Current PrepaidMaintenanceContractsCurrent	324000	usd
CY2023Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	2195000	usd
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	1640000	usd
CY2023Q1	shc	Prepaid Software Licensing Current PrepaidSoftwareLicensingCurrent	1854000	usd
CY2022Q4	shc	Prepaid Software Licensing Current PrepaidSoftwareLicensingCurrent	1832000	usd
CY2023Q1	us-gaap	Supplies Supplies	3639000	usd
CY2022Q4	us-gaap	Supplies Supplies	3656000	usd
CY2023Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Asset EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset	2507000	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Asset EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset	2721000	usd
CY2023Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	6375000	usd
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	0	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	11873000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9101000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87303000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	80995000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1101768000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1652000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1103420000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	961991000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	592944000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	102813000	usd
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1064804000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	592944000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	959264000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	570626000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	102627000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1061891000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	570626000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	60084000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	79986000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	42584000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	22227000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	21150000	usd
CY2023Q1	shc	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	143016000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	369047000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26250000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	32936000	usd
CY2023Q1	shc	Litigation Settlement Reserve Current LitigationSettlementReserveCurrent	408000000	usd
CY2022Q4	shc	Litigation Settlement Reserve Current LitigationSettlementReserveCurrent	408000000	usd
CY2023Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	3651000	usd
CY2022Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	3776000	usd
CY2023Q1	shc	Accrued Interest Expense Current AccruedInterestExpenseCurrent	27714000	usd
CY2022Q4	shc	Accrued Interest Expense Current AccruedInterestExpenseCurrent	23291000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3524000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3508000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	16222000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6436000	usd
CY2023Q1	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	1913000	usd
CY2022Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	1906000	usd
CY2023Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	2320000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	2392000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	2654000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2567000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4543000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5318000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	496791000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	490130000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2263550000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9709000	usd
CY2023Q1	shc	Debt Instrument Unamortized Discount Excluding Current Portion DebtInstrumentUnamortizedDiscountExcludingCurrentPortion	27477000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	2226364000	usd
CY2023Q1	shc	Long Term Debt Current Maturities Gross LongTermDebtCurrentMaturitiesGross	4200000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	60000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	109000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	4031000	usd
CY2023Q1	shc	Long Term Debt Gross Noncurrent LongTermDebtGrossNoncurrent	2259350000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	9649000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	27368000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2222333000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1963550000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5471000	usd
CY2022Q4	shc	Debt Instrument Unamortized Discount Excluding Current Portion DebtInstrumentUnamortizedDiscountExcludingCurrentPortion	13845000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1944234000	usd
CY2022Q4	shc	Long Term Debt Current Maturities Gross LongTermDebtCurrentMaturitiesGross	200450000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	3331000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	197119000	usd
CY2022Q4	shc	Long Term Debt Gross Noncurrent LongTermDebtGrossNoncurrent	1763100000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2140000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	13845000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1747115000	usd
CY2023Q1	shc	Debt Instrument Prepayment Period Without Penalty DebtInstrumentPrepaymentPeriodWithoutPenalty	P6M
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	2950000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5000000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5000000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2250600000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2023Q1	shc	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2263550000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.474
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.323
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2842000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	30641000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	18000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	338000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2824000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2824000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30303000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	30303000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	280691000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	279829000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2286000	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	79000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	282977000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	279908000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4062000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3061000	shares
CY2023Q1	shc	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability Per Occurrence LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence	10000000	usd
CY2023Q1	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	20000000	usd
CY2023Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	2727300000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	26669000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	5934000	usd
CY2022Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	2331400000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	37485000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3780000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-3372000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	6179000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-9275000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	0	usd
CY2023Q1	shc	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndAfterTax	-12647000	usd
CY2022Q1	shc	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndAfterTax	6179000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2600000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1900000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	6300000	usd
CY2023Q1	shc	Cancellation Fee Received For Lease Termination CancellationFeeReceivedForLeaseTermination	1000000	usd

Files In Submission

Name	View Source	Status
0001822479-23-000033-index-headers.html	Edgar Link	pending
0001822479-23-000033-index.html	Edgar Link	pending
0001822479-23-000033.txt	Edgar Link	pending
0001822479-23-000033-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shc-20230331.htm	Edgar Link	pending
shc-20230331.xsd	Edgar Link	pending
shc-20230331_def.xml	Edgar Link	unprocessable
shc-20230331_g1.jpg	Edgar Link	pending
shc20230331_exhibitx10x3.htm	Edgar Link	pending
shc20230331_exhibitx31x2.htm	Edgar Link	pending
shc20230331_exhibitx32x1.htm	Edgar Link	pending
shc_20230331xexhibitx10x2.htm	Edgar Link	pending
shc_20230331xexhibitx31x1.htm	Edgar Link	pending
Show.js	Edgar Link	pending
shc-20230331_cal.xml	Edgar Link	unprocessable
shc-20230331_pre.xml	Edgar Link	unprocessable
shc-20230331_lab.xml	Edgar Link	unprocessable
shc-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHC
Sotera Health Co Stock $shc

2023 Q2 Form 10-Q Financial Statement

#000182247923000033 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHC Sotera Health Co Stock $shc

2023 Q2 Form 10-Q Financial Statement

#000182247923000033 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHC
Sotera Health Co Stock $shc